MRNA Today - Aug 08: FDA Clearance, Stock Slides

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

MRNA Today - Aug 08: FDA Clearance, Stock Slides

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly investor buddy. I’ve been in the game for years, and today we’re talking about Moderna. So, it was a red day for MRNA, with the stock sliding down about 9.9%. Ouch, right?

So, what happened? Well, despite the excitement around Moderna getting FDA clearance for its flu vaccine, the stock didn’t really catch fire. It actually dropped. I know, kinda wild. You’d think good news would send it soaring, but nope. Instead, it got smoked.

Now, why’d it slide? A few reasons floating around. First off, even with the FDA nod, there’s some skepticism in the market. Investors are a bit on edge about how well the flu vaccine will perform and if it can really boost sales. Plus, there’s chatter about stock sales from the CEO under a Rule 10b5-1 plan, which kinda raised eyebrows. When the boss is cashing in, people start to wonder, you know? It’s like, “Is he seeing something we’re not?” And that uncertainty got folks hitting the sell button pretty fast.

Oh, and there’s this whole “buy the dip” buzz going on, but honestly, it didn’t help today. A lot of people just seem to be waiting to see how this all plays out.

One quick thing to keep in mind is that Moderna’s still got its hands in the game with mRNA tech, and they’re working on a bunch of stuff beyond just COVID and flu vaccines. So, they’re not out of the race yet.

Alright, that’s a wrap for today! Just remember, this is all for fun and info, not financial advice. Stay chill, and catch you later!

まだレビューはありません